Want to join the conversation?
Bayer's acquisition of $MON is subject to customary closing conditions, including Monsanto's shareholder approval and receipt of required regulatory approvals. Closing is expected by the end of 2017. Bayer has committed to a $2Bil reverse antitrust break fee, reaffirming its confidence that it will obtain the necessary regulatory approvals.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?